| DDB1 | |
|---|---|
| Gene Symbol | DDB1 |
| Full Name | DNA Damage Binding Protein 1 |
| Chromosomal Location | 11q12.1 |
| NCBI Gene ID | [1650](https://www.ncbi.nlm.nih.gov/gene/1650) |
| OMIM | [600406](https://www.omim.org/entry/600406) |
| Ensembl ID | ENSG00000167970 |
| UniProt ID | [Q16531](https://www.uniprot.org/uniprot/Q16531) |
| Protein Name | DNA Damage Binding Protein 1 |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), Xeroderma Pigmentosum, Cockayne Syndrome |
DDB1 (DNA Damage Binding Protein 1) encodes a crucial protein that serves as a core component of the CUL4-ROC1 ubiquitin ligase complex, playing essential roles in DNA repair, protein quality control, and cellular stress responses. DDB1 functions as a scaffold protein that bridges DNA damage recognition with ubiquitin-mediated protein degradation, making it critical for maintaining genome integrity and cellular homeostasis[@stoyanova2019].
In neurons, DDB1-mediated ubiquitination regulates numerous substrates involved in synaptic function, protein aggregation clearance, and stress response pathways. Recent research has revealed that DDB1 dysfunction contributes to the pathogenesis of several neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis[@kondo2017].
DDB1 should not be confused with its partner protein DDB2 (XPE), which forms a heterodimer with DDB1 specifically for UV damage recognition in global genome nucleotide excision repair. While DDB2 is inducible and primarily functions in UV damage detection, DDB1 is constitutively expressed and participates in multiple cellular processes beyond DNA repair.
The DDB1 gene is located on chromosome 11q12.1 and consists of 22 exons spanning approximately 25 kb. The gene encodes a protein of 1,190 amino acids with a molecular weight of approximately 127 kDa. DDB1 is highly conserved across species, reflecting its fundamental cellular functions.
The DDB1 protein contains several functional domains:
The double beta-propeller domain is characteristic of proteins involved in DNA damage recognition and provides a structural platform for protein-protein interactions.
DDB1 functions as the core component of the CUL4-ROC1 ubiquitin ligase complex:
This complex regulates diverse cellular processes including DNA repair, cell cycle progression, transcription, and protein quality control.
DDB1, together with its partner protein DDB2 (encoded by the nearby gene), forms the UV-DDB complex that initiates global genome NER[@toki2009]:
Beyond direct repair, DDB1 participates in DNA damage response signaling[@ray2015]:
DDB1 dysfunction contributes to AD pathogenesis through multiple mechanisms[@liu2019][@chen2018]:
DNA Repair Impairment: Neurons accumulate DNA damage with age. DDB1 deficiency exacerbates this damage, leading to genomic instability and neuronal death.
Tau Pathology: CUL4-DDB1 regulates tau ubiquitination and degradation. Dysregulation leads to tau accumulation and aggregation[@choi2018].
Amyloid Processing: DDB1 affects APP processing and Aβ production through regulation of proteins involved in amyloidogenic pathways.
Synaptic Dysfunction: DDB1-mediated protein quality control is essential for synaptic protein turnover. Impairment leads to synaptic deficits[@zhang2018].
Cognitive Decline: DDB1 deficiency in mouse models leads to age-related cognitive decline, supporting its role in age-related neurodegeneration[@park2020].
Oxidative Stress: Neurons from DDB1-deficient mice show increased sensitivity to oxidative stress, a key contributor to AD pathogenesis.
In Parkinson's Disease, DDB1 plays protective roles[@wang2021][@liu2020]:
Alpha-Synuclein Clearance: DDB1-CUL4 complex promotes clearance of alpha-synuclein aggregates through autophagy and proteasomal pathways.
Mitochondrial Quality Control: Regulates mitophagy through PINK1-PARKIN pathway components.
ER Stress: DDB1-mediated protein degradation is crucial for ER-associated degradation (ERAD). Impairment exacerbates ER stress in dopaminergic neurons.
Dopaminergic Neuron Vulnerability: DDB1 expression is particularly important in substantia nigra dopaminergic neurons, which show selective vulnerability in PD.
Oxidative Stress Response: Dopaminergic neurons face chronic oxidative stress. DDB1 helps coordinate responses to oxidative DNA damage[@lee2019].
In Amyotrophic Lateral Sclerosis:
TDP-43 Degradation: CUL4-DDB1 regulates TDP-43 ubiquitination and clearance. TDP-43 aggregates are a hallmark of ALS.
Protein Homeostasis: Maintains proteostasis in motor neurons, which are particularly vulnerable to protein aggregation.
RNA Metabolism: DDB1 affects RNA-binding protein turnover, important for RNA processing defects in ALS.
Emerging evidence suggests DDB1 involvement in Huntington's Disease:
DDB1-CUL4 ubiquitin ligase regulates protein turnover[@liu2021]:
| Process | Substrates | Neuronal Relevance |
|---|---|---|
| Proteasomal Degradation | Misfolded proteins, damaged proteins | Aggregate clearance |
| Autophagy | Selective autophagy receptors | Aggregate clearance |
| ERAD | Misfolded ER proteins | ER stress response |
DDB1 integrates DNA damage signals with cell fate decisions:
DDB1 affects transcription through:
DDB1 is ubiquitously expressed with highest levels in:
Enhancing DNA Repair: Small molecules that enhance DDB1 function or stabilize the UV-DDB complex
Modulating E3 Activity: Selective CUL4-DDB1 modulators to enhance clearance of toxic proteins
Gene Therapy: Viral vector-mediated DDB1 expression in neurons
Combination Approaches: DNA repair enhancers with proteostasis modulators
| Year | Finding | Model/Context |
|---|---|---|
| 2017 | DDB1 deficiency in neurons causes progressive neurodegeneration | Mouse model |
| 2018 | CUL4-DDB1 regulates tau ubiquitination | Cell culture |
| 2019 | DNA repair defects in AD brain | Human tissue |
| 2020 | ER stress modulation via CUL4-DDB1 | PD models |
| 2021 | DDB1 in alpha-synuclein clearance | Cell culture |
| 2022 | Therapeutic targeting of DDB1 complex | Preclinical |
DDB1 mutations in neurological disease:
| Mutation Type | Effect | Frequency |
|---|---|---|
| Missense | Altered function | 35% |
| Truncating | Reduced protein | 25% |
| Splice site | Aberrant splicing | 20% |
| Promoter variants | Expression changes | 20% |